Global Bioreactors Market Report and Forecast 2024-2032

Global Bioreactors Market Outlook

The global bioreactors market size was approximately USD 7.12 billion in 2023. The market is further projected to grow at a CAGR of 10.7% in the forecast period of 2024-2032, reaching a value of around USD 17.77 billion by 2032.

Key Trends in the Market

Bioreactors are devices, systems, or vessels that are able to support an environment that is biologically active, enabling controlled chemical and biological reactions. Various processes, including aerobic and anaerobic, can be conducted in bioreactors, involving biochemically active materials or organisms. Bioreactors are suited for large scale and high-volume productions and reactions, and are commonly used for fermentation processes.

• Increasing prevalence of chronic and acute health conditions and the thriving pharmaceutical industry are driving the bioreactors market growth. Bioreactors are vital in the development of new pharmaceuticals and vaccines and in mass production.

• Advancements in technology of bioreactors to support a wider range of processes and reactions is one of the crucial bioreactors market trends. With the ability of bioreactors to change and monitor processes, more complex reactions can be performed in an accurate and scalable manner.

• The demand for bioreactors from contract manufacturing organisations (CMOs) is rising amidst the increasing significance of outsourcing product development by healthcare firms. The rising demand for large-scale manufacturing of healthcare products can be conveniently met through CMOs, leading to increased production outsourcing and thus, favouring the market expansion.

Market Analysis

Based on material, the market is divided into glass, stainless steel, and polymer/plastic. On the basis of control type, the market is bifurcated into manual and automated. By usage, the bioreactors market segmentation includes lab-scale production, pilot-scale production, and full-scale production.

Based on capacity, the market is categorised into 5L-20L, 20L-200L, 200L-1500L, and above 1500L. On the basis of suppliers, the market is classified into OEM and EPCs. The regional markets for bioreactors are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global bioreactors market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

• INFORS HT.

• Solida Biotech GmBH

• Bailun Biotech (Jiangsu) Co., LTD

• Merck KGaA

• Kuhner AG

• Sartorius AG

• Thermo Fisher Scientific Inc.

• Cytiva

• PBS Biotech, Inc. 

• Getinge AB

• Others

Market Share by Material

Single-use bioreactors account for a significant portion of the bioreactors market share, supported by their lower costs, greater flexibility, and increased efficiency. The vessels for single-use bioreactors are pre-sterilised and already equipped with the required sensors, impellers, and spargers, leading to quick and easy usage.

Single-use bioreactors are often the preferred choice for the biopharmaceutical industry as their pre-sterilised nature aids in preventing any risk of cross contamination which can be time consuming and damage entire product batches. The various layers and components of single-use bioreactors can be customised as per the need of the process, providing greater flexibility and efficiency, which further supports the demand for single-use bioreactors.

Market Share by Region

At a regional level, North America occupies a sizable share of the global bioreactors market, fuelled by the growing pharmaceuticals and biotechnology sectors in the region. Countries in North America, such as the United States and Canada, are increasingly investing in localised production capacities for various biopharmaceutical products, thereby increasing the demand for bioreactors.

Moreover, extensive research and development activities are also surging the demand for bioreactors to manufacture new drugs and ingredients to treat a variety of new health conditions. Collaborations between key players, academic institutes, and industries are also anticipated to aid the bioreactors market demand in North America over the coming years.

Competitive Landscape

INFORS HT. develops and produces high-tech and advanced solutions for the biotechnology sector, specialising in shaker incubators, bioprocess control software, and bioreactors. Founded in 1965 and currently based in Basel-Landschaft, Switzerland, the company focuses on simplifying the workflows of biotechnology customers through the use of innovative technology.

Solida Biotech GmBH, headquartered in Munich, Germany, engineers, develops, and manufactures bioprocess equipment, providing institutional and industrial clients with new generation fermenters and bioreactors for diagnostics, research, and production. The company offers flexible solutions for fermentation, cell culture, and white, green, and red biotechnologies.

Merck KGaA is among the oldest chemical and pharmaceutical companies in the world, founded in 1668. Currently based in Darmstadt, Germany, the company holds expertise in life sciences, healthcare, and electronics, with a key focus on research and development to develop innovative products.

Other market players include Bailun Biotech (Jiangsu) Co., LTD, Kuhner AG, Sartorius AG, Thermo Fisher Scientific Inc., Cytiva, PBS Biotech, Inc., and Getinge AB, among others.

Key Highlights of the Report